Previous studies have explored the potential for viruses such as HPV and EBV to interact with genetic mutations such as those in the KRAS gene to determine whether synergistic mutations exist that contribute to the initiation or progression of cancer.7 However, the specific relationship between these viruses and KRAS remains an area of ongoing research characterized by complex and multifaceted mechanisms. This evidence concerns the gene KRAS and cancer.